Search clinical trials for: CY6463

Total 5 results

Tisento Therapeutics
Children's Hospital of Philadelphia

Terminated

Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)

MELAS

United States
Tisento Therapeutics

Completed

Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia

Schizophrenia

United States
Tisento Therapeutics

Terminated

A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology

Alzheimer's Disease With Vascular Pathology

United States
Tisento Therapeutics

Terminated

IW-6463 Safety Study in Healthy Elderly Subjects

Other

Netherlands
Tisento Therapeutics

Completed

A Study of IW-6463 in Healthy Volunteers

Other

Netherlands

3

Subscribe